Ringer's Lactate
(BPKIGYQJPYCAOW-FFJTTWKXSA-I)
Structure
- SMILES
- [O-]C(=O)[C@@H](O)C.O.[Na+].[Na+].[Cl-].[Cl-].[K+].[Ca+2].[OH-].[OH-]
- Molecular Formula:
- C3H9CaCl2KNa2O6
- Molecular Weight:
- 337.162
- Log P:
- -8.2928
- Hydrogen Bond Acceptor:
- 6
- Hydrogen Bond Donor:
- 4
- TPSA:
- 115.71
- CAS Number(s):
- 8026-79-7
Synonym(s)
1.
Ringer's Lactate
2.
Hartmann's Solution
3.
Hartmanns Solution
4.
Lactated Ringer's Solution
5.
Lactated Ringers Solution
6.
Ringer's, Lactated
7.
Ringers Lactate
8.
Lactate, Ringer's
9.
Lactate, Ringers
10.
Lactated Ringer Solution
11.
Lactated Ringer's
12.
Ringer's Solution, Lactated
13.
Ringers Solution, Lactated
External Link(s)
| MeSH | D000077325 |
| PubChem Compound | 56841910 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Blindness | FAERS: 102 | US FAERS | |
| 2 | Pruritus | FAERS: 19 | US FAERS | |
| 3 | Urticaria | FAERS: 19 | US FAERS | |
| 4 | Burning sensation | FAERS: 15 | US FAERS | |
| 5 | Hypersensitivity | FAERS: 14 | US FAERS | |
| 6 | Drug exposure during pregnancy | FAERS: 13 | US FAERS | |
| 7 | Chest discomfort | FAERS: 12 | US FAERS | |
| 8 | Erythema | FAERS: 11 | US FAERS | |
| 9 | Chest Pain | FAERS: 7 | US FAERS | |
| 10 | Throat irritation | FAERS: 7 | US FAERS | |
| 11 | Chills | FAERS: 6 | US FAERS | |
| 12 | Leukocytosis | FAERS: 6 | US FAERS | |
| 13 | Medication Error | FAERS: 6 | US FAERS | |
| 14 | Pain | FAERS: 6 | US FAERS | |
| 15 | Poor quality drug administered | FAERS: 5 | US FAERS | |
| 16 | Anxiety | FAERS: 4 | US FAERS | |
| 17 | Flushing | FAERS: 4 | US FAERS | |
| 18 | Infusion site erythema | FAERS: 4 | US FAERS | |
| 19 | Transmission of an infectious agent via a medicinal product | FAERS: 4 | US FAERS | |
| 20 | Hypotension | FAERS: 3 | US FAERS | |
| 21 | Infusion site pruritus | FAERS: 3 | US FAERS | |
| 22 | Injection Site Reaction | FAERS: 3 | US FAERS | |
| 23 | No adverse event | FAERS: 3 | US FAERS | |
| 24 | Pharmaceutical product complaint | FAERS: 3 | US FAERS | |
| 25 | Poor sanitation | FAERS: 3 | US FAERS | |
| 26 | Therapeutic product contamination | FAERS: 3 | US FAERS | |
| 27 | Wrong drug administered | FAERS: 3 | US FAERS | |
| 28 | Anaphylactic shock | FAERS: 2 | US FAERS | |
| 29 | Anaphylactoid Reaction | FAERS: 2 | US FAERS | |
| 30 | Bronchospasm | FAERS: 2 | US FAERS | |
| 31 | Dysgeusia | FAERS: 2 | US FAERS | |
| 32 | Feeling abnormal | FAERS: 2 | US FAERS | |
| 33 | Infusion site burning | FAERS: 2 | US FAERS | |
| 34 | Injection site erythema | FAERS: 2 | US FAERS | |
| 35 | Procedural complication | FAERS: 2 | US FAERS | |
| 36 | Product container issue | FAERS: 2 | US FAERS | |
| 37 | Product contamination | FAERS: 2 | US FAERS | |
| 38 | Productive Cough | FAERS: 2 | US FAERS | |
| 39 | Stridor | FAERS: 2 | US FAERS | |
| 40 | Abdominal Pain | FAERS: 1 | US FAERS | |
| 41 | Accidental exposure to product | FAERS: 1 | US FAERS | |
| 42 | Apathy | FAERS: 1 | US FAERS | |
| 43 | Back Pain | FAERS: 1 | US FAERS | |
| 44 | Bacterial culture positive | FAERS: 1 | US FAERS | |
| 45 | Blood glucose increased | FAERS: 1 | US FAERS | |
| 46 | Blood potassium increased | FAERS: 1 | US FAERS | |
| 47 | Escherichia urinary tract infection | FAERS: 1 | US FAERS | |
| 48 | Eye inflammation | FAERS: 1 | US FAERS | |
| 49 | Feeling Cold | FAERS: 1 | US FAERS | |
| 50 | Headache | FAERS: 1 | US FAERS | |
| 51 | Infusion site pain | FAERS: 1 | US FAERS | |
| 52 | Infusion site reaction | FAERS: 1 | US FAERS | |
| 53 | Injection site irritation | FAERS: 1 | US FAERS | |
| 54 | Injection site pruritus | FAERS: 1 | US FAERS | |
| 55 | Injection site urticaria | FAERS: 1 | US FAERS | |
| 56 | No reaction on previous exposure to drug | FAERS: 1 | US FAERS | |
| 57 | Occupational exposure to product | FAERS: 1 | US FAERS | |
| 58 | Pallor | FAERS: 1 | US FAERS | |
| 59 | Palmar erythema | FAERS: 1 | US FAERS | |
| 60 | Pleurisy | FAERS: 1 | US FAERS | |
| 61 | Pneumonia | FAERS: 1 | US FAERS | |
| 62 | Product contamination physical | FAERS: 1 | US FAERS | |
| 63 | Product deposit | FAERS: 1 | US FAERS | |
| 64 | Product outer packaging issue | FAERS: 1 | US FAERS | |
| 65 | Product quality issue | FAERS: 1 | US FAERS | |
| 66 | Pulmonary Embolism | FAERS: 1 | US FAERS | |
| 67 | Rash erythematous | FAERS: 1 | US FAERS | |
| 68 | Respiratory arrest | FAERS: 1 | US FAERS | |
| 69 | Sense of oppression | FAERS: 1 | US FAERS | |
| 70 | Sepsis | FAERS: 1 | US FAERS | |
| 71 | Thermal burn | FAERS: 1 | US FAERS | |
| 72 | Vomiting | FAERS: 1 | US FAERS | |
| 73 | Wound infection pseudomonas | FAERS: 1 | US FAERS | |
| 74 | Wrong technique in drug usage process | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.